Mucus
Pricing Report NDC 46122-417-74

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Mucus Extended Release (NDC 46122-417-74) is $0.45964 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 20, 2021.

As a provided by Amerisourcebergen Drug Corporation, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.45964
Per EA

Effective Date
Jan 20, 2021
Billable Units
1 EA
Estimated Package Price
$0.46
Data Status
As of Jan 27, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.45222 to $0.47343 per EA. Over this 1 year and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4522 - $0.4734
Market Volatility
4.69% Variance
Latest Trend
0.68%
Date Unit Price Unit Source Method Rate
Jan 20, 2021 $0.45964 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 23, 2020 $0.46277 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 18, 2020 $0.46230 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2020 $0.46231 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $0.46382 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2020 $0.45222 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2020 $0.46034 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2020 $0.45955 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2020 $0.46849 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2020 $0.46519 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.45264 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.47176 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.46387 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.47343 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.46465 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.46465 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 18, 2019 $0.46415 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026